Consistently, in vivo BrdU labeling and analysis of CD31+BrdU+ proliferating cells within harvested cells from tumors indicated significant lowering of proliferating cells in tumor bearing mice pretreated with NLGP (Figure 5D.3). Here, PECAM1 is linked to neoplasm.